Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms.

Bombaci M, Pesce E, Torri A, Carpi D, Crosti M, Lanzafame M, Cordiglieri C, Sinisi A, Moro M, Bernuzzi F, Gerussi A, Geginat J, Muratori L, Terracciano LM, Invernizzi P, Abrignani S, Grifantini R.

Liver Int. 2019 Nov;39(11):2124-2135. doi: 10.1111/liv.14128. Epub 2019 May 15.

PMID:
31033124
2.

Computation and Selection of Optimal Biomarker Combinations by Integrative ROC Analysis Using CombiROC.

Bombaci M, Rossi RL.

Methods Mol Biol. 2019;1959:247-259. doi: 10.1007/978-1-4939-9164-8_16.

PMID:
30852827
3.

Correction for Gallo et al., "RACK1 Specifically Regulates Translation through Its Binding to Ribosomes".

Gallo S, Ricciardi S, Manfrini N, Pesce E, Oliveto S, Calamita P, Mancino M, Maffioli E, Moro M, Crosti M, Berno V, Bombaci M, Tedeschi G, Biffo S.

Mol Cell Biol. 2019 Jan 16;39(3). pii: e00544-18. doi: 10.1128/MCB.00544-18. Print 2019 Feb 1. No abstract available.

4.

RACK1 Specifically Regulates Translation through Its Binding to Ribosomes.

Gallo S, Ricciardi S, Manfrini N, Pesce E, Oliveto S, Calamita P, Mancino M, Maffioli E, Moro M, Crosti M, Berno V, Bombaci M, Tedeschi G, Biffo S.

Mol Cell Biol. 2018 Nov 13;38(23). pii: e00230-18. doi: 10.1128/MCB.00230-18. Print 2018 Dec 1. Erratum in: Mol Cell Biol. 2019 Jan 16;39(3):.

5.

Enhancing Antibody Serodiagnosis Using a Controlled Peptide Coimmobilization Strategy.

Sola L, Gagni P, D'Annessa I, Capelli R, Bertino C, Romanato A, Damin F, Bergamaschi G, Marchisio E, Cuzzocrea A, Bombaci M, Grifantini R, Chiari M, Colombo G, Gori A, Cretich M.

ACS Infect Dis. 2018 Jun 8;4(6):998-1006. doi: 10.1021/acsinfecdis.8b00014. Epub 2018 Mar 29.

PMID:
29570266
6.

TCTN2: a novel tumor marker with oncogenic properties.

Cano-Rodriguez D, Campagnoli S, Grandi A, Parri M, Camilli E, Song C, Jin B, Lacombe A, Pierleoni A, Bombaci M, Cordiglieri C, Ruiters MH, Viale G, Terracciano L, Sarmientos P, Abrignani S, Grandi G, Pileri P, Rots MG, Grifantini R.

Oncotarget. 2017 Aug 24;8(56):95256-95269. doi: 10.18632/oncotarget.20438. eCollection 2017 Nov 10.

7.

Lack of evidence for post-vaccine onset of autoimmune/lymphoproliferative disorders, during a nine-month follow-up in multiply vaccinated Italian military personnel.

Ferlito C, Barnaba V, Abrignani S, Bombaci M, Sette A, Sidney J, Biselli R, Tomao E, Cattaruzza MS, Germano V, Biondo MI, Salerno G, Lulli P, Caporuscio S, Picchianti Diamanti A, Falco M, Biselli V, Cardelli P, Autore A, Lucertini E, De Cesare DP, Peragallo MS, Lista F, Martire C, Salemi S, Nisini R, D'Amelio R.

Clin Immunol. 2017 Aug;181:60-66. doi: 10.1016/j.clim.2017.06.001. Epub 2017 Jun 15.

PMID:
28625884
8.

CombiROC: an interactive web tool for selecting accurate marker combinations of omics data.

Mazzara S, Rossi RL, Grifantini R, Donizetti S, Abrignani S, Bombaci M.

Sci Rep. 2017 Mar 30;7:45477. doi: 10.1038/srep45477.

9.

Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis.

Mazzara S, Sinisi A, Cardaci A, Rossi RL, Muratori L, Abrignani S, Bombaci M.

PLoS One. 2015 Sep 16;10(9):e0137927. doi: 10.1371/journal.pone.0137927. eCollection 2015.

10.

Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis.

Zingaretti C, Arigò M, Cardaci A, Moro M, Crosti M, Sinisi A, Sugliano E, Cheroni C, Marabita F, Nogarotto R, Bonnal RJ, Marcatili P, Marconi M, Zignego A, Muratori P, Invernizzi P, Colombatto P, Brunetto M, Bonino F, De Francesco R, Geginat J, Pagani M, Muratori L, Abrignani S, Bombaci M.

Mol Cell Proteomics. 2012 Dec;11(12):1885-97. doi: 10.1074/mcp.M112.018713. Epub 2012 Sep 20.

11.

Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case.

Bensi G, Mora M, Tuscano G, Biagini M, Chiarot E, Bombaci M, Capo S, Falugi F, Manetti AG, Donato P, Swennen E, Gallotta M, Garibaldi M, Pinto V, Chiappini N, Musser JM, Janulczyk R, Mariani M, Scarselli M, Telford JL, Grifantini R, Norais N, Margarit I, Grandi G.

Mol Cell Proteomics. 2012 Jun;11(6):M111.015693. doi: 10.1074/mcp.M111.015693. Epub 2012 Jan 27.

12.

Surface interactome in Streptococcus pyogenes.

Galeotti CL, Bove E, Pezzicoli A, Nogarotto R, Norais N, Pileri S, Lelli B, Falugi F, Balloni S, Tedde V, Chiarot E, Bombaci M, Soriani M, Bracci L, Grandi G, Grifantini R.

Mol Cell Proteomics. 2012 Apr;11(4):M111.015206. doi: 10.1074/mcp.M111.015206. Epub 2011 Dec 22.

13.

Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against Group A Streptococcus antigens.

Bombaci M, Grifantini R, Mora M, Reguzzi V, Petracca R, Meoni E, Balloni S, Zingaretti C, Falugi F, Manetti AG, Margarit I, Musser JM, Cardona F, Orefici G, Grandi G, Bensi G.

PLoS One. 2009 Jul 22;4(7):e6332. doi: 10.1371/journal.pone.0006332.

14.

Capturing host-pathogen interactions by protein microarrays: identification of novel streptococcal proteins binding to human fibronectin, fibrinogen, and C4BP.

Margarit I, Bonacci S, Pietrocola G, Rindi S, Ghezzo C, Bombaci M, Nardi-Dei V, Grifantini R, Speziale P, Grandi G.

FASEB J. 2009 Sep;23(9):3100-12. doi: 10.1096/fj.09-131458. Epub 2009 May 5.

PMID:
19417080
15.

Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation.

Manetti AG, Zingaretti C, Falugi F, Capo S, Bombaci M, Bagnoli F, Gambellini G, Bensi G, Mora M, Edwards AM, Musser JM, Graviss EA, Telford JL, Grandi G, Margarit I.

Mol Microbiol. 2007 May;64(4):968-83.

16.

Identification of major proteins secreted by Cryptococcus neoformans.

Biondo C, Mancuso G, Midiri A, Bombaci M, Messina L, Beninati C, Teti G.

FEMS Yeast Res. 2006 Jun;6(4):645-51.

17.

Characterization of two novel cryptococcal mannoproteins recognized by immune sera.

Biondo C, Messina L, Bombaci M, Mancuso G, Midiri A, Beninati C, Cusumano V, Gerace E, Papasergi S, Teti G.

Infect Immun. 2005 Nov;73(11):7348-55.

18.

MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans.

Biondo C, Midiri A, Messina L, Tomasello F, Garufi G, Catania MR, Bombaci M, Beninati C, Teti G, Mancuso G.

Eur J Immunol. 2005 Mar;35(3):870-8.

19.

Induction of T helper type 1 responses by a polysaccharide deacetylase from Cryptococcus neoformans.

Biondo C, Beninati C, Bombaci M, Messina L, Mancuso G, Midiri A, Galbo R, Teti G.

Infect Immun. 2003 Sep;71(9):5412-7.

20.

Identification and cloning of a cryptococcal deacetylase that produces protective immune responses.

Biondo C, Beninati C, Delfino D, Oggioni M, Mancuso G, Midiri A, Bombaci M, Tomaselli G, Teti G.

Infect Immun. 2002 May;70(5):2383-91.

Supplemental Content

Loading ...
Support Center